AR043210A1 - Compuestos de triazol utiles en terapia - Google Patents
Compuestos de triazol utiles en terapiaInfo
- Publication number
- AR043210A1 AR043210A1 ARP040100495A ARP040100495A AR043210A1 AR 043210 A1 AR043210 A1 AR 043210A1 AR P040100495 A ARP040100495 A AR P040100495A AR P040100495 A ARP040100495 A AR P040100495A AR 043210 A1 AR043210 A1 AR 043210A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- independently represent
- optionally substituted
- ring
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
Un compuesto de fórmula (1) o un derivado farmacéuticamente aceptable del mismo, donde V representa -(CH2)d(O)e-, -CO- o -CH(alquilo C1-6)-; W es -O-, -S(O)a- o -N(R1)-, R1 representa H, alquilo C1-6, -(CH2)bCOR2, CO(CH2)bNR2R3, SO2R2, (CH2)cOR2, (CH2)cNR2R3 o (CH2)bhet1; het1 representa un heterociclo saturado o insaturado de 3 a 8 átomos que contiene uno o más heteroátomos seleccionados entre O, N o S, opcionalmente sustituido con alquilo C1-6; X e Y representan independientemente H, alquilo C1-6, halógeno, OH, CF3, OCF3, OR4; Z representa -(CH2)f(O)g-, -CO- o -CH(alquilo C1-6)-; El anillo A representa un heterociclo saturado que contiene N de 4-7 miembros, opcionalmente sustituido con OH y en el que opcionalmente al menos un N de anillo está sustituido con O; El anillo B representa fenilo o un heterociclo insaturado que contiene N de 4-7 miembros, opcionalmente sustituido con OH, halógeno, CN, CONH2, CF3, OCF3 y en el que opcionalmente al menos un N de anillo está sustituido con O; R2 y R3 representan independientemente H, alquilo C1-6 [opcionalmente sustituido con OH, halógeno, N(alquilo C1-6)2 o alquiloxi C1-6], alquiloxi C1-6, N(alquilo C1-6)2 o [cicloalquilo C3-8]; o R2 y R3, junto con el átomo de N al que están unidos, representan independientemente un heterociclo de 3 a 8 átomos, opcionalmente sustituido con alquilo C1-6; R4 representa alquilo C1-6 lineal o ramificado, a y c representan independientemente 0, 1 o 2; b, e y g representan independientemente 0 o 1; y d y f representan independientemente 1 o 2; son útiles en el tratamiento de la dismenorrea. Procedimientos para la preparación del compuesto, intermediarios y formulación farmacéutica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0303852.8A GB0303852D0 (en) | 2003-02-19 | 2003-02-19 | Triazole compounds useful in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043210A1 true AR043210A1 (es) | 2005-07-20 |
Family
ID=9953327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040100495A AR043210A1 (es) | 2003-02-19 | 2004-02-18 | Compuestos de triazol utiles en terapia |
Country Status (11)
Country | Link |
---|---|
CN (1) | CN1751047A (es) |
AR (1) | AR043210A1 (es) |
CL (1) | CL2004000293A1 (es) |
GB (1) | GB0303852D0 (es) |
GT (1) | GT200400020A (es) |
NL (1) | NL1025527C2 (es) |
PA (1) | PA8596101A1 (es) |
PE (1) | PE20050222A1 (es) |
TW (1) | TW200500367A (es) |
UY (1) | UY28201A1 (es) |
WO (1) | WO2004074291A1 (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0325021D0 (en) * | 2003-10-27 | 2003-12-03 | Pfizer Ltd | Therapeutic combinations |
US7745630B2 (en) | 2003-12-22 | 2010-06-29 | Justin Stephen Bryans | Triazolyl piperidine arginine vasopressin receptor modulators |
DE102004001871A1 (de) * | 2004-01-14 | 2005-09-01 | Bayer Healthcare Ag | Tricyclische Benzazepin-Derivate und ihre Verwendung |
US7456170B2 (en) | 2004-08-25 | 2008-11-25 | Pfizer Inc. | Triazolobenzodiazepines and their use as vasopressin antagonists |
JP2008539220A (ja) * | 2005-04-26 | 2008-11-13 | ファイザー・リミテッド | バソプレシンアンタゴニストとしてのトリアゾール誘導体 |
KR101348499B1 (ko) | 2008-11-13 | 2014-01-06 | 에프. 호프만-라 로슈 아게 | 스피로-5,6-다이하이드로-4h-2,3,5,10b-테트라아자-벤조〔e〕아줄렌 |
SI2358714T1 (sl) * | 2008-11-18 | 2012-11-30 | Hoffmann La Roche | Alkilcikloheksiletri dihidrotetraazabenzoazulenov |
NZ592076A (en) | 2008-11-28 | 2012-06-29 | Hoffmann La Roche | Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists |
EP2414361A1 (en) | 2009-03-31 | 2012-02-08 | ArQule, Inc. | Substituted heterocyclic compounds |
EP2501685A1 (en) * | 2009-11-16 | 2012-09-26 | Mellitech | [1,5]-diazocin derivatives |
US8420633B2 (en) * | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8461151B2 (en) | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
US8492376B2 (en) * | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8481528B2 (en) * | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8513238B2 (en) * | 2010-05-10 | 2013-08-20 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
US9006450B2 (en) * | 2010-07-01 | 2015-04-14 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical compositions and uses thereof |
MX2013003749A (es) | 2010-10-07 | 2013-05-09 | Takeda Pharmaceutical | Derivados de 1,4-oxazepano. |
RU2011122942A (ru) | 2011-06-08 | 2012-12-20 | Общество С Ограниченной Ответственностью "Асинэкс Медхим" | Новые ингибиторы киназ |
US8828989B2 (en) * | 2011-09-26 | 2014-09-09 | Hoffmann-La Roche Inc. | Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists |
JP6062948B2 (ja) * | 2011-10-05 | 2017-01-18 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | V1aアンタゴニストとしてのシクロヘキシル−4H,6H−5−オキサ−2,3,10b−トリアザ−ベンゾ[e]アズレン |
IN2014DN09346A (es) | 2012-06-13 | 2015-07-17 | Hoffmann La Roche | |
CN102766674A (zh) * | 2012-07-25 | 2012-11-07 | 辉源生物科技(上海)有限公司 | 食蟹猴抗利尿激素受体v1a拮抗剂筛选平台的建立 |
EA036630B1 (ru) | 2012-09-25 | 2020-12-02 | Ф. Хоффманн-Ля Рош Аг | Бициклические производные |
AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
CA2919738A1 (en) | 2013-08-19 | 2015-02-26 | F. Hoffmann-La Roche Ag | V1a antagonists to treat phase shift sleep disorders |
PE20160845A1 (es) | 2013-11-26 | 2016-09-10 | Hoffmann La Roche | Nuevo octahidro-ciclobuta[1,2-c;3,4-c']dipirrol-2-ilo |
MY175464A (en) | 2013-12-05 | 2020-06-29 | Hoffmann La Roche | Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crytalline forms thereof |
ES2753549T3 (es) | 2014-03-26 | 2020-04-13 | Hoffmann La Roche | Compuestos bicíclicos como inhibidores de la producción de autotaxina (ATX) y ácido lisofosfatídico (LPA) |
CA2935612A1 (en) | 2014-03-26 | 2015-10-01 | F. Hoffmann-La Roche Ag | Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
CA2992889A1 (en) | 2015-09-04 | 2017-03-09 | F. Hoffmann-La Roche Ag | Phenoxymethyl derivatives |
KR20180054830A (ko) | 2015-09-24 | 2018-05-24 | 에프. 호프만-라 로슈 아게 | 오토탁신(atx) 억제제로서의 이환형 화합물 |
MX2018001890A (es) | 2015-09-24 | 2018-06-20 | Hoffmann La Roche | Compuestos biciclicos como inhibidores de autotaxina (atx). |
KR20180054634A (ko) | 2015-09-24 | 2018-05-24 | 에프. 호프만-라 로슈 아게 | 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 신규한 이환형 화합물 |
BR112017026682A2 (pt) | 2015-09-24 | 2018-08-14 | Hoffmann La Roche | novos compostos bicíclicos como inibidores de dupla ação de atx/ca |
KR20190129924A (ko) | 2017-03-16 | 2019-11-20 | 에프. 호프만-라 로슈 아게 | 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 유용한 헤테로환형 화합물 |
WO2018167113A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | New bicyclic compounds as atx inhibitors |
WO2018226769A1 (en) | 2017-06-05 | 2018-12-13 | Blackthorn Therapeutics, Inc. | 1-(2-azaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine derivatives as v1a receptor antagonists for treating neuropsychological disorders |
TW201938171A (zh) | 2017-12-15 | 2019-10-01 | 匈牙利商羅特格登公司 | 作為血管升壓素V1a受體拮抗劑之三環化合物 |
HU231206B1 (hu) | 2017-12-15 | 2021-10-28 | Richter Gedeon Nyrt. | Triazolobenzazepinek |
CN111170983B (zh) * | 2019-12-26 | 2021-07-09 | 中国农业大学 | 一种苄硫基乙酰胺类化合物及其制备方法与应用 |
CN114644635B (zh) * | 2020-12-21 | 2023-02-03 | 上海济煜医药科技有限公司 | 三氮唑类三并环衍生物及其制备方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8823475D0 (en) * | 1988-10-06 | 1988-11-16 | Merck Sharp & Dohme | Chemical compounds |
US5438035A (en) * | 1994-06-24 | 1995-08-01 | American Cyanamid Company | Methods for controlling undesirable plant species with benzodiazepine compounds |
US5753648A (en) * | 1995-01-17 | 1998-05-19 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
EP1021444B1 (en) * | 1996-11-01 | 2003-09-24 | Wyeth | 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES |
ME00129B (me) * | 1999-01-19 | 2010-10-10 | Ortho Mcneil Janssen Pharmaceuticals Inc | Triciklicnj benzodiazepini kao antagonisti receptora vazopresina |
US7109193B2 (en) * | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
-
2003
- 2003-02-19 GB GBGB0303852.8A patent/GB0303852D0/en not_active Ceased
-
2004
- 2004-02-09 WO PCT/IB2004/000432 patent/WO2004074291A1/en active IP Right Grant
- 2004-02-09 CN CNA2004800047089A patent/CN1751047A/zh active Pending
- 2004-02-17 PE PE2004000165A patent/PE20050222A1/es not_active Application Discontinuation
- 2004-02-18 PA PA20048596101A patent/PA8596101A1/es unknown
- 2004-02-18 AR ARP040100495A patent/AR043210A1/es not_active Application Discontinuation
- 2004-02-18 CL CL200400293A patent/CL2004000293A1/es unknown
- 2004-02-18 GT GT200400020A patent/GT200400020A/es unknown
- 2004-02-18 TW TW093103978A patent/TW200500367A/zh unknown
- 2004-02-19 NL NL1025527A patent/NL1025527C2/nl not_active IP Right Cessation
- 2004-02-19 UY UY28201A patent/UY28201A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN1751047A (zh) | 2006-03-22 |
NL1025527C2 (nl) | 2005-03-14 |
WO2004074291A1 (en) | 2004-09-02 |
GT200400020A (es) | 2004-09-21 |
NL1025527A1 (nl) | 2004-08-23 |
UY28201A1 (es) | 2004-09-30 |
PE20050222A1 (es) | 2005-04-13 |
PA8596101A1 (es) | 2005-08-04 |
CL2004000293A1 (es) | 2005-01-07 |
GB0303852D0 (en) | 2003-03-26 |
TW200500367A (en) | 2005-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR043210A1 (es) | Compuestos de triazol utiles en terapia | |
ECSP055973A (es) | Compuestos de triazol utiles en terapia | |
AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
AR044543A1 (es) | Derivados de pirazolo-quinazolina, un procedimiento para su preparacion y su uso como inhibidor de quinasa | |
TW200700061A (en) | Organic compounds | |
AR060159A2 (es) | Combinaciones de compuestos derivados de tropano utiles en terapia | |
CO5690599A2 (es) | Derivados de 3-(4-aminofenil) tienopirimid-4-ona como antagonistas mch r1 para el tratamiento de obesidad, diabetes, depresion y ansiedad | |
AR035617A1 (es) | Compuestos derivados de fenetanolamina, combinaciones y formulaciones farmaceuticas de los mismos, proceso para su preparacion, su uso en la preparacion de medicamentos para el tratamiento o profilaxis de una condicion clinica para la cual se indica un agonista beta2 adreno-receptor e intermediarios | |
NO20064297L (no) | Aminoalkoholforbindelse | |
ECSP045483A (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso | |
RU2000129161A (ru) | Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт | |
EP1634874A4 (en) | imidazolidine | |
AR041246A1 (es) | Derivados de piridina; un procedimiento de preparacion de los mismos y composicion farmaceutica que los contiene | |
AR043259A1 (es) | Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello | |
JP2002537284A5 (es) | ||
DE69400791D1 (de) | 5-Amino-8-methyl-7-pyrrolidinylchinolin-3-Carbonsäurederivat | |
AR046874A1 (es) | Nuevos metodos | |
EA199800013A1 (ru) | Способы минимизации остеопороза | |
AR042887A1 (es) | Derivados de diarilmetiden piperidina preparaciones y usos de los mismos | |
AR036351A1 (es) | Isoxazolopiridinonas, el uso de las mismas para la fabricacion de un medicamento, composiciones y combinaciones farmaceuticas | |
AR041896A1 (es) | Derivados de 4(fenil-piperazinil-metil) benzamida y sus usos para el tratamiento del dolor y desordenes gastrointestinales | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
ATE185145T1 (de) | 11 beta-benzaldoxim-9 alpha, 10 alpha-epoxy-estr- 4-en-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische präparate | |
DOP2004000827A (es) | Compuestos de traizol utiles en terapia | |
DE69414396D1 (de) | Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |